News & Events about Outset Medical Inc.
Outset Medical, Inc. (Nasdaq: OM) (Outset), a medical technology company reducing the cost and complexity of dialysis with its Tablo Hemodialysis System, is presenting five new abstracts providing promising insights on the clinical and financial benefits of home hemodialysis (HHD), gender biases...
Outset Medical, Inc. (Nasdaq: OM) (Outset), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the first quarter of 2023 after the close of trading on Wednesday, May 3...
Outset Medical, Inc. (NASDAQ:OM Get Rating) CEO Leslie Trigg sold 30,000 shares of the companys stock in a transaction on Wednesday, February 1st. The shares were sold at an average price of $28.06, for a total value of $841,800.00. Following the completion of the transaction, the ...
Outset Medical, Inc. (Nasdaq: OM) (Outset), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the fourth quarter and full year of 2022 after the close of trading on Monday...
Outset Medical, Inc. (Nasdaq: OM) (Outset or the Company), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported expected revenue for the fourth quarter and fiscal year ended December 31, 2022. Fourth Quarter and Year...